20AM 20mg*10vials

5-Amino-1MQ 20AM 20mg*10vials

5-Amino-1MQ is a novel small molecule research compound designed to inhibit NNMT (Nicotinamide N-methyltransferase), an enzyme that consumes NAD+ and regulates cellular metabolism. It represents a high-concentration research compound in metabolic and longevity studies.

The 20mg single-vial specification delivers four times the active ingredient content of the standard 5mg. This formulation is designed for ultra-long-term metabolic studies, high-dose NAD+ pathway validation experiments, and large-scale multi-group parallel research projects. The high concentration per vial minimizes the number of vials required for extended experimental timelines, effectively reducing data variability and operational errors from repeated dilution and solution preparation.

Through its NNMT inhibitory action, 5-Amino-1MQ supports comprehensive research into cellular NAD+ level maintenance, fat metabolism regulation, and energy production. It is designed to study how blocking NNMT can preserve NAD+ availability, supporting metabolic health, fat reduction, and cellular energy balance.

This product is supplied as sterile lyophilized powder in glass vials, formulated for reconstitution with bacteriostatic water. Each batch undergoes comprehensive purity testing, with a full certificate of analysis provided.

10 vials per pack, designed for large-scale preclinical research and extended metabolic laboratory projects.